Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1132500

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Disability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what impact assessment his Department has conducted of the effect on people with disabilities of the UK leaving the EU without a deal.
	tabling member constituency	Cardiff Central
	tabling member printed	Jo Stevens
	uin	265545
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>No formal impact assessment has been conducted by the Department of the effect on people with disabilities of the United Kingdom leaving the European Union without a deal.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/06/2019 09:26:59 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4425 label Biography information for Jo Stevens

1132444

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Steroid Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure continuity of supply for steroid treatments in the event that the UK leaves the EU without a deal.
	tabling member constituency	Luton South
	tabling member printed	Mr Gavin Shuker
	uin	265503
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The Government remains committed to leaving the European Union with a deal. However, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a potential ‘no deal’ scenario.</p><p>The Government fully understands that maintaining access to steroid treatments is vitally important to many people in this country. We are continuing to work with trade bodies and other stakeholders to carefully review the implications of the extension to the Article 50 period until 31 October at the latest, before sharing further guidance with industry at the earliest opportunity.</p><p> </p><p>On 26 April we wrote to suppliers advising that, until further guidance is provided, all no-deal measures (such as stockpiles, additional buffer stocks, etc) should remain in place but on hold.</p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/06/2019 09:28:01 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4013 label Biography information for Mr Gavin Shuker

1132599

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Out-patients: Attendance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the cost to the public purse of missed (a) GP and (b) hospital appointments.
	tabling member constituency	Tewkesbury
	tabling member printed	Mr Laurence Robertson
	uin	265416
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>Information surrounding the cost of missed general practitioner and hospital appointments is not collected or held centrally.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/06/2019 09:32:08 answering member 4455 label Biography information for Seema Kennedy
	tabling member	253 label Biography information for Mr Laurence Robertson

1132403

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what contingency plans his Department has put in place in the event that Vertex declines NHS England’s latest offer for the supply of Orkambi.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	265417
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS England is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi, and Symkevi in advance of assessment by the National Institute for Health and Care Excellence (NICE), and expanded access to Kalydeco which is already funded on the National Health Service for certain patients.</p><p>The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to urge Vertex to accept NHS England’s generous offer, but we will explore other options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 265418 question first answered 20/06/2019 09:33:36 answering member 4455 label Biography information for Seema Kennedy
	tabling member	298 label Biography information for Steve McCabe

1132404

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor: Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of launching a large scale clinical trial of the generic version of Orkambi.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	265418
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS England is leading the negotiations with Vertex and has made a revised and improved offer to Vertex that would provide immediate funding for Orkambi, and Symkevi in advance of assessment by the National Institute for Health and Care Excellence (NICE), and expanded access to Kalydeco which is already funded on the National Health Service for certain patients.</p><p>The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the NHS, and it is not for Ministers to intervene in this process. The Department’s approach remains to urge Vertex to accept NHS England’s generous offer, but we will explore other options to ensure patients can access treatments as soon as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 265417 question first answered 20/06/2019 09:33:36 answering member 4455 label Biography information for Seema Kennedy
	tabling member	298 label Biography information for Steve McCabe

1132476

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Reciprocal Arrangements
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the Government will extend the commitment to reimburse EU Member States for the cost of providing healthcare to UK nationals in the event that the UK leaves the EU without a deal and until the UK has secured a reciprocal healthcare agreement with the respective member state which provides for the reimbursement of costs.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	265407
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The United Kingdom Government has proposed to European Union Member States that, in a no-deal scenario, we should maintain the existing healthcare arrangements until 31 December 2020, with the aim of minimising disruption to UK nationals’ and EU citizens’ healthcare provision. This is subject to negotiations, which are ongoing. For UK nationals that live in EU Member States, the UK cannot unilaterally guarantee the continuation of current arrangements, as this depends on decisions by Member States.</p><p>Individuals are always responsible for ensuring they have sufficient healthcare insurance. Anyone who is living, working or studying in EU Member States should check the country specific guidance on GOV.UK and NHS.UK for updates.</p><p><br> The UK Government has committed to fund healthcare for UK nationals (and others for whom the UK is responsible) who have applied for, or are undergoing, treatments in the EU prior to and on exit day, for up to one year, to protect the most vulnerable.</p><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/06/2019 10:29:30 answering member 1585 label Biography information for Stephen Hammond
	tabling member	151 label Biography information for Tom Brake

1132430

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pathology: Vacancies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the level of vacancy is in histopathology departments.
	tabling member constituency	Totnes
	tabling member printed	Dr Sarah Wollaston
	uin	265511
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS Improvement publishes vacancy data for three staff groups; doctors, nurses and ‘other staff’. These vacancy statistics are published for England and at the regional level of North, Midlands and East, London and South.</p><p>They do not specifically produce vacancy data for histopathology departments or any vacancy data for each National Health Service hospital or trust.</p><p>NHS Digital published the latest NHS Improvement vacancy data which can be found in the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-vacancies-survey/february-2015---march-2019-provisional-experimental-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-vacancies-survey/february-2015---march-2019-provisional-experimental-statistics</a></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/06/2019 13:12:02 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4073 label Biography information for Dr Sarah Wollaston

1132431

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy Integration Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the current balance of the pharmacy integration fund is; and what initiatives have been supported by that fund since its inception.
	tabling member constituency	Rother Valley
	tabling member printed	Sir Kevin Barron
	uin	265429
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS England and NHS Improvement are awaiting the completion of the annual audit of its accounts, therefore no final figure is currently available for the balance of the Pharmacy Integration Fund (PhIF). The PhIF has supported a range of initiatives, including:</p><p>- Recruitment and training of pharmacists to support integrated urgent care services, offering patients and care staff direct access to clinical advice and care from pharmacists;</p><p>- Putting pharmacists and pharmacy technicians into the multi-disciplinary teams delivering enhanced health in care homes, to support medicines optimisation for people who live in care homes;</p><p>- The development of an urgent medicines supply service. This connects people who contact NHS 111 for urgent access to medicines with local community pharmacies who are able to dispense, and redirects demand out of general practitioner out of hours services, and/or accident and emergency departments;</p><p>- The piloting of a minor illness service, which enables people who contact NHS 111 to get urgent care and advice from a local community pharmacy for a range of common illness complaints; and</p><p>- Providing leadership training for the profession to support them to work effectively with their partners in the emerging integrated care systems, with a focus on delivering the range of benefits of medicines optimisation.</p><p>Further information can be found on NHS England’s website and accessed via the following link:</p><p><a href="https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-integration-fund/" target="_blank">https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-integration-fund/</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/06/2019 14:13:14 answering member 4455 label Biography information for Seema Kennedy
	tabling member	392 label Biography information for Sir Kevin Barron

1132424

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Skin Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the number of cases of melanoma.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	265456
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>On 16 June 2014, a local pilot campaign launched in Devon, Cornwall and Somerset to raise awareness of the signs of skin cancer. It encouraged people to tell their doctor if they noticed any unusual or persistent changes to their skin. It ran until 27 July 2014 and included adverts in the press and on local radio, as well as some direct mail to the target group.</p><p> </p><p>Skin Cancer awareness month is an annual awareness campaign that takes place every May. The campaign aims to raise awareness of the dangers of unprotected sun exposure and educate the public about the ways to help prevent skin cancer.</p><p>The Sunbeds (Regulation) Act 2010 came into force in April 2011 in England and Wales to prohibit under-18s from using sunbeds.</p><p> </p><p>Public Health England (PHE) contributed to the revision of the World Health Organization publication “Artificial tanning devices - Public health interventions to manage sunbeds”, which was published in 2017. PHE advises that sunbeds emit ultraviolet radiation, which can cause tanning and sunburn.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/06/2019 14:14:40 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1409 label Biography information for Mr Gregory Campbell

1132563

	registered interest
	date	17/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicine: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment of the effect on the UK's future participation in future EU Research Programmes in (a) medical research and (b) drugs of the UK leaving the EU without a deal.
	tabling member constituency	Mid Sussex
	tabling member printed	Sir Nicholas Soames
	uin	265405
	answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>Leaving the European Union with a deal remains the Government’s priority. However, as a responsible Government, we must plan for every eventuality, including ‘no deal’.</p><p>The United Kingdom and the EU have a long record of jointly tackling global challenges, with strong existing links already in place between our research and innovation communities, and we want to continue this important collaboration in science, research and innovation, including in medical research.</p><p>The Government is committed to continuing to back UK researchers and innovators by supporting measures to enable world-class collaborative research, including support for small businesses. The Department for Business, Energy and Industrial Strategy is working with the National Academies, the devolved administrations and UK Research and Innovation to develop ambitious and credible alternatives to association, through which we will enable world class collaborative research.</p><p>In addition, earlier in the year, the Minister of State for Universities, Science, Research and Innovation (Chris Skidmore MP) commissioned Sir Adrian Smith to provide independent advice on international collaboration – specifically on potential future UK funding schemes in the context of the UK’s future ambitions for European and international collaboration on research and innovation. His advice will help set the direction for the implementation of the Government’s ambition to ensure the UK continues to be a global leader in science, research and innovation, and an attractive country for individuals to study and work.</p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/06/2019 15:30:04 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	116 label Biography information for Lord Soames of Fletching